Deka Bank Deutsche Girozentrale Kura Oncology, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$54.1 Billion
Q4 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 95,000 shares of KURA stock, worth $783,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,000

Previous 95,000 -0.0%

Holding current value

$783,750

Previous $1.83 Million 55.9%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$7.58 - $14.38 $492,700 - $934,700	65,000 Added 216.67%	95,000 $1.34 Million
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $253,199 - $355,800	30,000 New	30,000 $262,000
Q1 2022 Apr 28, 2022	BUY	$11.78 - $16.98 $27,094 - $39,054	2,300 Added 10.18%	24,900 $401,000
Q4 2021 Feb 02, 2022	BUY	$12.22 - $19.57 $7,332 - $11,742	600 Added 2.73%	22,600 $328,000
Q2 2021 Aug 05, 2021	SELL	$20.85 - $29.88 $938,250 - $1.34 Million	-45,000 Reduced 67.16%	22,000 $470,000
Q4 2020 Mar 12, 2021	SELL	$29.0 - $41.62 $2.01 Million - $2.89 Million	-69,400 Reduced 50.88%	67,000 $2.26 Million
Q3 2020 Oct 29, 2020	BUY	$16.3 - $30.64 $2.22 Million - $4.18 Million	136,400 New	136,400 $4.13 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $289,100 - $409,052	-19,600 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$14.71 - $19.79 $111,796 - $150,404	7,600 Added 63.33%	19,600 $388,000
Q1 2019 May 10, 2019	BUY	$13.73 - $16.87 $30,206 - $37,114	2,200 Added 22.45%	12,000 $235,000
Q4 2018 Feb 12, 2019	SELL	$10.6 - $17.49 $23,320 - $38,478	-2,200 Reduced 18.33%	9,800 $127,000
Q3 2018 Nov 09, 2018	SELL	$16.65 - $21.85 $4,995 - $6,555	-300 Reduced 2.44%	12,000 $0
Q1 2018 May 03, 2018	BUY	$14.5 - $23.4 $178,350 - $287,820	12,300 New	12,300 $226,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $552M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Kura Oncology, Inc. Transaction History